Assessment of serum ɛN-carboxymethyllysine and soluble receptor of advanced glycation end product levels among type 2 diabetes mellitus patients with and without acute coronary syndrome

Journal Title: International Journal of Medical Science and Public Health - Year 2018, Vol 7, Issue 11

Abstract

Background: One of the most predominant macrovascular complications of type 2 diabetes mellitus (T2DM) is acute coronary syndrome (ACS). Advanced glycation end products (AGEs) play an important role in the development and progression of ACS in T2DM patients. The soluble receptor of AGEs (sRAGE) decoys the effect of AGEs by binding with them. Objectives: The objectives of the study were to measure serum ɛN-carboxymethyllysine (CML) and sRAGE levels among T2DM with and without ACS and to find out whether serum CML and sRAGE could be used to predict the risk of ACS among T2DM patients. Materials and Methods: A total of 37 T2DM patients with ACS were selected as cases and 37 T2DM as controls. Routine biochemical parameters were carried out on autoanalyzer and serum CML and sRAGE were estimated by ELISA. The data were recorded and analyzed on SPSS system and were compared by Student’s t-test or Mann–Whitney test. Results: Serum CML level and CML/sRAGE ratio were significantly increased in the cases as compared to control. Correlation analyses showed that serum CML concentration and serum CML/sRAGE ratio were positively correlated with weight, waist circumference, body mass index and serum urea, and very low-density lipoprotein-cholesterol. Multivariate regression (Binary logistics) analysis after adjusted for waist circumference, weight, BMI, and systolic blood pressure showed that serum CML was significantly associated with ACS risk among T2DM patients. Receiver operating characteristic curve depicted that high CML level (>31.83 ng/ml) and CML/sRAGE ratio (>15.48) were associated with greatest risk of ACS among type 2 DM patients. Conclusion: T2DM patients with high serum CML concentration and CML/sRAGE ratio were at risk of ACS independent of other cardiovascular risks.

Authors and Affiliations

Shanija S, Prashant Shankarrao Adole, Kolar Vishwanath Vinod, Rama Prakasha Saya

Keywords

Related Articles

Assessment of Sahiyya (Accredited Social Health Activist) in Relation to Child Health in Ranchi, Jharkhand

Background: Accredited social health activist (ASHA) is one of the key components of national rural health mission (NRHM) who can play an important role in identifying child morbidity at the earliest and...

Obesity and comorbid conditions: An urban population-based cross-sectional study in Northwest India

Background: Obesity of late has become a challenge for public health planners both in developing as well as the developed nations. Obesity has assumed pandemic proportions worldwide. Objectives: (1) To determine the prev...

 Predictor factors for relapse after remission of seizure in adults with remote symptomatic epilepsy

 Background: Several studies have examined remission in individuals with epilepsy and relied on factors that may affect seizure outcome. However, the information on those patients with remote symptomatic epilepsy w...

Depression and anxiety as comorbid disorders in patients with Type II diabetes

Background:India is on the verge of a potential epidemic for Type II diabetes with the second highest diabetic population in the world. Similarly, depression and anxiety are global mental health disorders of public healt...

Download PDF file
  • EP ID EP489579
  • DOI 10.5455/ijmsph.2018.0721728072018
  • Views 74
  • Downloads 0

How To Cite

Shanija S, Prashant Shankarrao Adole, Kolar Vishwanath Vinod, Rama Prakasha Saya (2018). Assessment of serum ɛN-carboxymethyllysine and soluble receptor of advanced glycation end product levels among type 2 diabetes mellitus patients with and without acute coronary syndrome. International Journal of Medical Science and Public Health, 7(11), 879-884. https://europub.co.uk./articles/-A-489579